Bültmann & Gerriets
Informed Consent
Patient Autonomy and Physician Beneficence within Clinical Medicine
von S. Wear
Verlag: Springer Netherlands
Reihe: Clinical Medical Ethics Nr. 4
Gebundene Ausgabe
ISBN: 978-0-7923-2029-6
Auflage: 1993
Erschienen am 31.12.1992
Sprache: Englisch
Format: 241 mm [H] x 160 mm [B] x 15 mm [T]
Gewicht: 453 Gramm
Umfang: 188 Seiten

Preis: 106,99 €
keine Versandkosten (Inland)


Dieser Titel wird erst bei Bestellung gedruckt. Eintreffen bei uns daher ca. am 22. Oktober.

Der Versand innerhalb der Stadt erfolgt in Regel am gleichen Tag.
Der Versand nach außerhalb dauert mit Post/DHL meistens 1-2 Tage.

klimaneutral
Der Verlag produziert nach eigener Angabe noch nicht klimaneutral bzw. kompensiert die CO2-Emissionen aus der Produktion nicht. Daher übernehmen wir diese Kompensation durch finanzielle Förderung entsprechender Projekte. Mehr Details finden Sie in unserer Klimabilanz.
Klappentext
Inhaltsverzeichnis

Substantial efforts have recently been made to reform the physician-patient relationship, particularly toward replacing the `silent world of doctor and patient' with informed patient participation in medical decision-making. This 'new ethos of patient autonomy' has especially insisted on the routine provision of informed consent for all medical interventions. Stronly supported by most bioethicists and the law, as well as more popular writings and expectations, it still seems clear that informed consent has, at best, been received in a lukewarm fashion by most clinicians, many simply rejecting what they commonly refer to as the `myth of informed consent'.
The purpose of this book is to defuse this seemingly intractable controversy by offering an efficient and effective operational model of informed consent. This goal is pursued first by reviewing and evaluating, in detail, the agendas, arguments, and supporting materials of its proponents and detractors. A comprehensive review of empirical studies of informed consent is provided, as well as a detailed reflection on the common clinician experience with attempts at informed consent and the exercise of autonomy by patients.
In the end, informed consent is recast as a management tool for pursuing clinically and ethically important goods and values that any clinician should see as meriting pursuit. Concurrently, the model incorporates a flexible, anticipatory approach that recognizes that no static, generic ritual can legitimately pursue the quite variable goods and values that may be at stake with different patients in different situations. Finally, efficiency of provision is addressed by not pursuing the unattainable and ancillary. Throughout, the traditional principle of beneficence is appealed to toward articulating an operational model of informed consent as an intervention that is likely to change outcomes at the bedside for the better.



I: The Sources of a Model of Informed Consent.- One: The Legal Doctrine of Informed Consent.- Two: The New Ethos of Patient Autonomy.- Three: The Clinical Experience of Patient Autonomy and Informed Consent.- Four: The Potential Benefits of Informed Consent.- II: A Model of Informed Consent.- Five: Toward a Model of Informed Consent - Theoretical and Programmatic Considerations.- Six: The Informed Consent Event.- Seven: The Issue of Competence.- Eight: Exceptions to Informed Consent.- Nine: The Enterprise of Informed Consent.


andere Formate
weitere Titel der Reihe